Birth Defects & Genetic Diseases Research organizations account for 182 organizations in the United States. In aggregate, these organizations generate $945m in revenue and employ 4.2k individuals.
182
Active Organizations
$945.2 Million
Annual Revenue
4 Thousand
Employees in Sector
$2.2 Billion
Controlled Assets
Cambridge, MA
Assets: $2b
Revenue: $587m
Employees: 3k
MISSION:
The goal of this organization is to conduct research which can be used to improve the prevention, diagnosis and treatment of any of a number of illnesses or conditions that are hereditary and passed from parent to offspring.
New York, NY
Assets: $76m
Revenue: $44m
Employees: 138
MISSION:
SEE SCHEDULE O.TO ADVANCE THE MOST CUTTING-EDGE STEM CELL RESEARCH IN THE WORLD, TO SUPPORT STEM CELL SCIENTISTS, AND TO EDUCATE THE PUBLIC.
Seattle, WA
Assets: $61m
Revenue: $44m
Employees: 109
MISSION:
TO RADICALLY ENABLE AND ADVANCE BIOMEDICAL DISCOVERY THROUGH THE DEVELOPMENT AND EXPLORATORY APPLICATION OF NEW TECHNOLOGIES AND APPROACHES FOR ILLUMINATING CELL AND TISSUE STATES AND FUNCTION. TO ACHIEVE THIS VISION, ALTIUS IS ESTABLISHING A WHOLLY NEW TYPE OF SCIENTIFIC AND TECHNOLOGICAL DISCOVERY ENVIRONMENT DESIGNED TO FOSTER LEAPS IN INNOVATION. ALTIUS WILL LEVERAGE ITS CUTTING-EDGE TECHNOLOGIES TO SPAN THE CHASM BETWEEN BASIC BIOLOGICAL DISCOVERIES RELATED TO THE FUNCTION OF CELLS AND TISSUES AND THE TRANSLATION OF THESE INSIGHTS INTO THE CLINICAL ARENA AND THE DEVELOPMENT OF NOVEL MEDICINES.
New York, NY
Assets: $57m
Revenue: $52m
Employees: 204
MISSION:
CARDIOVASCULAR RESEARCH FOUNDATION IS AN INDEPENDENT, ACADEMICALLY FOCUSED ORGANIZATION DEDICATED TO IMPROVING THE SURVIVAL AND QUALITY OF LIFE FOR PEOPLE WITH CARDIOVASCULAR DISEASE THROUGH RESEARCH AND EDUCATION. THE ORGANIZATION HAS PLAYED A MAJOR ROLE IN REALIZING DRAMATIC IMPROVEMENTS IN THE LIVES OF COUNTLESS NUMBERS OF PATIENTS BY ESTABLISHING THE SAFE USE OF NEW TECHNOLOGIES AND THERAPIES IN THE SUBSPECIALTY OF INTERVENTIONAL CARDIOLOGY AND ENDOVASCULAR MEDICINE.
New York, NY
Assets: $47m
Revenue: $26m
Employees: 109
MISSION:
THE NATIONAL HEMOPHILIA FOUNDATION (NHF) IS DEDICATED TO FINDING CURES FOR INHERITABLE BLOOD DISORDERS AND TO ADDRESSING AND PREVENTING THE COMPLICATIONS OF THESE DISORDERS THROUGH RESEARCH, EDUCATION, AND ADVOCACY ENABLING PEOPLE AND FAMILIES TO THRIVE.
Basking Ridge, NJ
Assets: $27m
Revenue: $15m
Employees: 32
MISSION:
THE FOUNDATION FOR EMBRYONIC COMPETENCE, INC., FORMERLY KNOWN AS " THE FOUNDATION FOR THE ASSESSMENT AND ENHANCEMENT OF EMBRYONIC COMPETENCE, INC." (FOUNDATION) IS A NEW JERSEY NON-PROFIT CORPORATION, INCORPORATED IN 2013. THE FOUNDATION'S ACTIVITIES ARE CONDUCTED AT ITS SOLE LOCATION, 140 ALLEN ROAD IN BASKING RIDGE, NEW JERSEY. THE MISSION OF THE FOUNDATION IS ADVANCING KNOWLEDGE AND ENHANCING OUTCOMES IN EMBRYONIC RESEARCH, DIAGNOSIS, AND EDUCATION.
Buffalo, NY
Assets: $26m
Revenue: $9m
Employees: 35
MISSION:
GUIDED BY ITS MOTTO, CURE-OSITY, THE HAUPTMAN-WOODWARD MEDICAL RESEARCH INSTITUTE (HWI) CREATES NOVEL STRATEGIES AND TECHNOLOGIES TO PROMOTE THE UNDERSTANDING, PREVENTION, AND TREATMENT OF MANY HUMAN DISEASES. HWI SCIENTISTS CONDUCT BASIC, FUNDAMENTAL RESEARCH THAT WILL PROVIDE THE FOUNDATION FOR EFFECTIVE THERAPEUTIC APPROACHES FAR INTO THE FUTURE. OFTEN OUR RESEARCH INCLUDES IDENTIFYING PROTEINS INVOLVED IN DISEASE WHICH ALLOWS TREATMENTS TO BE MORE EFFECTIVE BY TARGETING THOSE PROTEINS. EXAMPLES OF CURRENT PROJECTS INCLUDE BREAST CANCER, PROSTATE CANCER, MULTIPLE MYELOMA, STUDYING THE EFFECT OF GRAVITY ON CELLS, AND BIOLOGICAL CELL STRUCTURE DETERMINATION FOR NEARLY ALL DISEASE THROUGH THE USE OF HARD X-RAY FREE ELECTRON LASERS (XFELS) AND HIGH-THROUGHPUT CRYSTALLIZATION.
Rockville, MD
Assets: $24m
Revenue: $8m
Employees: 36
MISSION:
The goal of this organization is to conduct research which can be used to improve the prevention, diagnosis and treatment of any of a number of illnesses or conditions that are hereditary and passed from parent to offspring.
Greenwood, SC
Assets: $23m
Revenue: $25m
Employees: 205
MISSION:
THE GREENWOOD GENETIC CENTER IS A NONPROFIT INSTITUTE CENTERED ON CLINICAL GENETIC SERVICES, DIAGNOSTIC LABORATORY TESTING, EDUCATIONAL PROGRAMS AND RESOURCES, AND RESEARCH. WITH A FOCUS ON COMPASSIONATE PATIENT CARE AND INNOVATIVE SCIENTIFIC ADVANCEMENT, WE KEEP EVERY PATIENT AND THEIR FAMILIES AT THE FOREFRONT OF EVERYTHING WE DO. WE HAVE A VARIETY OF CLINIC LOCATIONS TO SERVE PATIENTS AND FAMILIES ACROSS THE LIFESPAN WITH A VARIETY OF GENETIC NEEDS AND CONCERNS.
Philadelphia, PA
Assets: $17m
Revenue: $52m
Employees: 278
MISSION:
The goal of this organization is to conduct research which can be used to improve the prevention, diagnosis and treatment of any of a number of illnesses or conditions that are hereditary and passed from parent to offspring.
New York, NY
Assets: $16m
Revenue: $4m
Employees: 3
MISSION:
TO FUND INNOVATIVE RESEARCH TOWARDS CURING HUNTINGTON'S DISEASE AND IMPACTING OTHER BRAIN DISORDERS.
New York, NY
Assets: $12m
Revenue: $6m
Employees: 7
MISSION:
PREVENT AND CURE HEARING LOSS AND TINNITUS THROUGH GROUNDBREAKING RESEARCH. (SEE SCH O ) HEARING HEALTH FOUNDATION'S VISION IS TO HAVE A WORLD WHERE PEOPLE CAN ENJOY LIFE WITHOUT HEARING LOSS AND TINNITUS. SINCE 1958, HEARING HEALTH FOUNDATION HAS BEEN THE LEADING NONPROFIT FUNDER FOR FUNDING FOR BASIC, CLINICAL AND TRANSLATIONAL RESEARCH IN HEARING AND BALANCE SCIENCE, AND A LEADER IN DRIVING NEW INNOVATIONS AND TREATMENTS FOR PEOPLE WITH HEARING LOSS, TINNITUS, AND OTHER HEARING CONDITIONS. THIS INCLUDES FUNDING RESEARCH THAT LED TO THE DEVELOPMENT OF COCHLEAR IMPLANTS AND MANY OF TODAY'S STANDARD TREATMENTS FOR OTOSCLEROSIS (ABNORMAL BONE GROWTH IN THE EAR) AND EAR INFECTIONS. IN THE 1990'S HEARING HEALTH FOUNDATION ADVOCATED IN WASHINGTON, DC, FOR THE UNIVERSAL NEWBORN HEARING SCREENING LEGISLATION, TO DETECT HEARING LOSS AT BIRTH. TODAY, 97% OF NEWBORNS ARE TESTED (UP FROM 4% IN 1994).
Waukesha, WI
Assets: $12m
Revenue: $7m
Employees: 30
MISSION:
ASGCT'S MISSION IS TO ADVANCE KNOWLEDGE, AWARENESS, AND EDUCATION LEADING TO THE DISCOVERY AND CLINICAL APPLICATION OF GENETIC AND CELLULAR THERAPIES TO ALLEVIATE HUMAN DISEASE.
Chicago, IL
Assets: $11m
Revenue: $6m
MISSION:
IMPROVE BLOOD AND MARROW TRANSPLANTATION AND RELATED CELLULAR THERAPIES
Cambridge, MA
Assets: $10m
Revenue: $2m
Employees: 29
MISSION:
TO FUNCTION AS A LOCAL AND NATIONAL CLINIC AND DIAGNOSTIC REFERENCE RESOURCE FOR BIRTH DEFECTS AND GENETIC DISORDERS.
San Juan, PR
Assets: $9m
Revenue: $11m
Employees: 52
MISSION:
EARLY INTERVENTION AND PRIMARY CLINIC DENTAL CARE CLINIC MENTAL HEALTH HIV ANTIBODY TESTING MEDICINE PROVISION MEDICAL CARE MANAGEM
Randolph, MA
Assets: $6m
Revenue: $4m
Employees: 17
MISSION:
INCREASE AWARENESS, UNDERSTANDING OF AND CONDUCT RESEARCH ON FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY.
Dallas, TX
Assets: $5m
Revenue: $4m
Employees: 23
MISSION:
TO SAVE LIVES THROUGH THE PREVENTION AND CURE OF OVARIAN CANCER AND TO IMPROVE THE QUALITY OF LIFE FOR SURVIVORS AND THEIR CAREGIVERS.
Reston, VA
Assets: $5m
Revenue: $2m
MISSION:
The goal of this organization is to conduct research which can be used to improve the prevention, diagnosis and treatment of any of a number of illnesses or conditions that are hereditary and passed from parent to offspring.
Assets: $5m
Revenue: $2m
MISSION:
TO DRIVE THE TRANSLATION OF ALL CELLULAR THERAPIES FOR THE BENEFIT OF PATIENTS WORLDWIDE.